| scholarly article | Q13442814 |
| P50 | author | Fiona Powrie | Q5451098 |
| P2093 | author name string | Christian Mottet | |
| Holm H Uhlig | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colitis | Q2453464 |
| P304 | page(s) | 3939-3943 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells | |
| P478 | volume | 170 |
| Q30433247 | A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis |
| Q79274153 | A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation |
| Q92314206 | A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease |
| Q55362406 | A Context-Dependent Role for αv Integrins in Regulatory T Cell Accumulation at Sites of Inflammation. |
| Q41891740 | A Novel mTORC1-Dependent, Akt-Independent Pathway Differentiates the Gut Tropism of Regulatory and Conventional CD4 T Cells. |
| Q37390209 | A central role for induced regulatory T cells in tolerance induction in experimental colitis |
| Q44877960 | A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitis |
| Q41750028 | A guide to histomorphological evaluation of intestinal inflammation in mouse models. |
| Q30830505 | A key role of dendritic cells in probiotic functionality |
| Q62040086 | A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2 |
| Q34359061 | A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features |
| Q53563995 | A potential screening tool for IPEX syndrome. |
| Q24622687 | A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity |
| Q34281595 | A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease |
| Q49551935 | Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis |
| Q28476563 | Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis |
| Q37800006 | Adaptive immunity in the host–microbiota dialog |
| Q37197488 | Affinity for self antigen selects Treg cells with distinct functional properties |
| Q85932260 | Alloreactive regulatory T cells generated with retinoic acid prevent skin allograft rejection |
| Q91722736 | Amiselimod (MT-1303), a novel sphingosine 1-phosphate receptor-1 functional antagonist, inhibits progress of chronic colitis induced by transfer of CD4+CD45RBhigh T cells |
| Q42114498 | An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy. |
| Q88407288 | An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis |
| Q37737823 | An expanding stage for commensal microbes in host immune regulation |
| Q54608720 | An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis. |
| Q46137528 | Analysis of the Foxp3/scurfin gene in Crohn's disease |
| Q33828647 | Analysis of the transcriptional program of developing induced regulatory T cells |
| Q38033380 | Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease |
| Q54536554 | Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. |
| Q86264935 | Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease |
| Q27307614 | Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mst1 kinase |
| Q84104592 | Antigen-specific suppression by induced CD4+CD25high regulatory T cells in kidney recipients |
| Q43769651 | Antioxidative and immunomodulatory effects of tributyrin supplementation on experimental colitis. |
| Q27006589 | Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease |
| Q48520123 | Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats. |
| Q36979743 | Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity |
| Q42523517 | Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action |
| Q92924396 | Bcl11b prevents fatal autoimmunity by promoting Treg cell program and constraining innate lineages in Treg cells |
| Q51438149 | Bee venom-associated Th1/Th2 immunoglobulin class switching results in immune tolerance of NZB/W F1 murine lupus nephritis. |
| Q56901901 | Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo |
| Q41813088 | Blocking lymphocyte localization to the gastrointestinal mucosa as a therapeutic strategy for inflammatory bowel diseases |
| Q34520569 | Blood and Gastric FOXP3+ T Cells Are Not Decreased in Human Gastric Graft-versus-Host Disease |
| Q36229439 | CCR4-dependent regulatory T cell function in inflammatory bowel disease |
| Q36228080 | CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence |
| Q60920701 | CCR9 Expressing T Helper and T Follicular Helper Cells Exhibit Site-Specific Identities During Inflammatory Disease |
| Q38432470 | CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease. |
| Q33416251 | CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients |
| Q36399104 | CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. |
| Q37366174 | CD25+ T cells induce Helicobacter pylori-specific CD25- T-cell anergy but are not required to maintain persistent hyporesponsiveness |
| Q55085752 | CD25+ regulatory T cells can be used therapeutically in collagen-induced arthritis. |
| Q36916914 | CD28 costimulation is essential for human T regulatory expansion and function |
| Q44548657 | CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study |
| Q50561082 | CD4 T cells are required for both development and maintenance of disease in a new mouse model of reversible colitis. |
| Q37076943 | CD4(+) T-cell subsets in intestinal inflammation |
| Q36986140 | CD4(+)CD25(+) T Cells in primary malignant hypertension related kidney injury |
| Q35694441 | CD4+ CD25+ Treg: divide and rule? |
| Q36371316 | CD4+ CD25+ regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo |
| Q56903729 | CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-β, and CTLA4 |
| Q36399063 | CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion |
| Q34063120 | CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2. |
| Q36275650 | CD4+CD25+ cells in multiple myeloma related renal impairment |
| Q36600237 | CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance |
| Q53517484 | CD4+CD25+ regulatory T cells have divergent effects on intestinal inflammation in IL-10 gene-deficient mice. |
| Q36478841 | CD4+CD25+ regulatory T cells in health and disease. |
| Q54560887 | CD4+CD25+ regulatory T cells in irritable bowel syndrome patients. |
| Q51968092 | CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. |
| Q36076203 | CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling |
| Q84348158 | CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model |
| Q37754524 | CD4+CD25+ regulatory T-cell therapy |
| Q34709777 | CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells |
| Q51041309 | CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris |
| Q35632116 | CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis. |
| Q60452024 | CD4+Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation |
| Q34707617 | CD8α+ plasmacytoid precursor DCs induce antigen-specific regulatory T cells that enhance HSC engraftment in vivo |
| Q39512153 | CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation |
| Q57062041 | CXCR6ST2 memory T helper 2 cells induced the expression of major basic protein in eosinophils to reduce the fecundity of helminth |
| Q54254429 | Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. |
| Q47550996 | Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function |
| Q90312722 | Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? |
| Q33796582 | Cancer inflammation and regulatory T cells |
| Q52668207 | Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype. |
| Q35916008 | Cell therapy for autoimmune diseases: does it have a future? |
| Q35092822 | Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP. |
| Q51853299 | Cell-cell-neighborhood relations in tissue sections--a quantitative model for tissue cytometry. |
| Q34276576 | Cell-permeable Foxp3 protein alleviates autoimmune disease associated with inflammatory bowel disease and allergic airway inflammation. |
| Q28081921 | Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease |
| Q40486270 | Characteristics of CD4(+)CD25(+)Foxp3(+) regulatory T cells in patients with multiple organ dysfunction syndrome |
| Q56902065 | Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats |
| Q61779891 | Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis |
| Q81036129 | Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo |
| Q37755313 | Chemokines, chemokine receptors and CD4+CD25+ regulatory T cells |
| Q37693490 | Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis! |
| Q36150414 | Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases |
| Q33367565 | Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation |
| Q30311883 | Combining Fas mutation with interleukin-2 deficiency prevents Colitis and Lupus: implicating interleukin-2 for auto-reactive T cell expansion and Fas ligand for colon epithelial cell death |
| Q33356616 | Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation |
| Q35949449 | Comparative Genomics Reveals Key Gain-of-Function Events in Foxp3 during Regulatory T Cell Evolution |
| Q84300301 | Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation |
| Q54056924 | Contrasting activity of cytosin–guanosin dinucleotide oligonucleotides in mice with experimental colitis |
| Q35970475 | Control of IFN-γ production and regulatory function by the inducible nuclear protein IκB-ζ in T cells. |
| Q89542076 | Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes |
| Q36242785 | Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. |
| Q37392233 | Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease |
| Q64885862 | Controlling Gut Inflammation by Restoring Anti-Inflammatory Pathways in Inflammatory Bowel Disease. |
| Q35016178 | Coordination of tolerogenic immune responses by the commensal microbiota |
| Q36026037 | Costimulation: critical pathways in the immunologic regulation of asthma |
| Q37272089 | Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored? |
| Q35848458 | Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease |
| Q35237502 | Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease |
| Q42617070 | Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg |
| Q36506677 | Current and future immunomodulation strategies to restore tolerance in autoimmune diseases |
| Q38260780 | Cutting edge: IFN-γR signaling in non-T cell targets regulates T cell-mediated intestinal inflammation through multiple mechanisms |
| Q36818290 | Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases |
| Q44948777 | Cytomics and nanobioengineering. |
| Q34412214 | Decrease of peripheral and intestinal NKG2A-positive T cells in patients with ulcerative colitis |
| Q35298358 | Decreased T-cell receptor signaling through CARD11 differentially compromises forkhead box protein 3-positive regulatory versus T(H)2 effector cells to cause allergy |
| Q22242645 | Defects in mucosal immunity leading to Crohn's disease |
| Q38703915 | Deficiency of Phosphatidylinositol 3-Kinase δ Signaling Leads to Diminished Numbers of Regulatory T Cells and Increased Neutrophil Activity Resulting in Mortality Due to Endotoxic Shock |
| Q36228938 | Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice |
| Q36563563 | Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. |
| Q37591719 | Dendritic cells in intestinal homeostasis and disease. |
| Q28593598 | Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells |
| Q28601365 | Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease |
| Q35992122 | Development and maintenance of intestinal regulatory T cells |
| Q37786736 | Developmental plasticity of Foxp3+ regulatory T cells |
| Q36399149 | Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells |
| Q82810873 | Diminution of Circulating CD4+CD25 high T cells in naïve Crohn's disease |
| Q26774590 | Disrupted regulatory T cell homeostasis in inflammatory bowel diseases |
| Q90233338 | Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation |
| Q50949144 | Dissecting memory T cell responses to TB: concerns using adoptive transfer into immunodeficient mice. |
| Q34075201 | Distinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal |
| Q37041928 | Distinct roles of helper T-cell subsets in a systemic autoimmune disease |
| Q64257546 | Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties |
| Q37631112 | Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines? |
| Q37106760 | Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. |
| Q37411301 | Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy. |
| Q52726744 | Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases. |
| Q54656483 | Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. |
| Q36672085 | Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease |
| Q57339016 | Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts |
| Q37477403 | Enhanced suppressive function of regulatory T cells from patients with immune-mediated diseases following successful ex vivo expansion |
| Q37049828 | Enlarged colitogenic T cell population paradoxically supports colitis prevention through the B-lymphocyte-dependent peripheral generation of CD4(+)Foxp3(+) Treg cells |
| Q54492437 | Enteroantigen (eAg)-binding B lymphocytes in the mouse - phenotype, distribution, function and eAg-specific antibody secretion. |
| Q34567635 | Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4 |
| Q50093819 | Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice |
| Q51013890 | Epigenetic reprogramming of the RORC locus during in vitro expansion is a distinctive feature of human memory but not naïve Treg. |
| Q36732716 | Epithelia: lymphocyte interactions in the gut. |
| Q24646106 | Essential role for CD103 in the T cell-mediated regulation of experimental colitis |
| Q35530818 | Evaluation of immunosuppressive function of regulatory T cells using a novel in vitro cytotoxicity assay |
| Q37644295 | Evolving paradigms in the pathogenesis of IBD. |
| Q33336577 | Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy |
| Q37610691 | Excessive expression of miR-27 impairs Treg-mediated immunological tolerance. |
| Q30434096 | Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease |
| Q37857437 | Experimental inflammatory bowel disease: insights into the host-microbiota dialog |
| Q38977353 | Expression of CD200R1 and its Ligand CD200 on T-helper Lymphocytes of Pediatric Patients with Ulcerative Colitis and Crohn's Disease. |
| Q35551308 | Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy |
| Q51776024 | FOXP3+ regulatory T-cell counts correlate with histological response in Crohn's colitis treated with infliximab. |
| Q41919734 | FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents |
| Q51983634 | FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis. |
| Q91810029 | Fibrogenesis in Chronic DSS Colitis is Not Influenced by Neutralisation of Regulatory T Cells, of Major T Helper Cytokines or Absence of IL-13 |
| Q63727335 | FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease |
| Q37104701 | Foxp3 processing by proprotein convertases and control of regulatory T cell function |
| Q54453217 | Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. |
| Q42263552 | G protein-coupled receptor kinase 6 controls chronicity and severity of dextran sodium sulphate-induced colitis in mice. |
| Q33752581 | GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cells |
| Q37969759 | Gene and cell therapy based treatment strategies for inflammatory bowel diseases |
| Q35514307 | Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells |
| Q36846255 | Ginseng Berry Extract Attenuates Dextran Sodium Sulfate-Induced Acute and Chronic Colitis. |
| Q87355832 | Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells |
| Q41978355 | Gliadin-primed CD4+CD45RBlowCD25- T cells drive gluten-dependent small intestinal damage after adoptive transfer into lymphopenic mice |
| Q37541716 | Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells |
| Q36190558 | Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice |
| Q40484358 | Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation |
| Q52626272 | Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissue. |
| Q36586957 | Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells |
| Q94948243 | HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases |
| Q35624877 | Harnessing regulatory T cells for the treatment of inflammatory bowel disease. |
| Q36480993 | Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis |
| Q53364227 | Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease. |
| Q58712085 | Helicobacter pylori infection and inflammatory bowel disease: a crosstalk between upper and lower digestive tract |
| Q38219027 | Helicobacter pylori infection and inflammatory bowel disease: is there a link? |
| Q40124338 | Helicobacter species are potent drivers of colonic T cell responses in homeostasis and inflammation |
| Q37235236 | Helminths and the IBD hygiene hypothesis |
| Q33867430 | Helminths in the gastrointestinal tract as modulators of immunity and pathology. |
| Q45971388 | Heme oxygenase-1 confers protection and alters T-cell populations in a mouse model of neonatal intestinal inflammation. |
| Q34159981 | Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. |
| Q81572282 | High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis |
| Q35096555 | Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells |
| Q37608561 | Histone deacetylase inhibitors modulate interleukin 6-dependent CD4+ T cell polarization in vitro and in vivo |
| Q40145396 | Histone methylation mediates plasticity of human FOXP3(+) regulatory T cells by modulating signature gene expressions |
| Q36251301 | Homeostatic T cell proliferation as a barrier to T cell tolerance |
| Q33868945 | Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease. |
| Q36019528 | Host-dependent control of early regulatory and effector T-cell differentiation underlies the genetic susceptibility of RAG2-deficient mouse strains to transfer colitis. |
| Q89475561 | Host-microbiota interactions in inflammatory bowel disease |
| Q33644234 | Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer |
| Q42072531 | Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision |
| Q42747705 | Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells |
| Q36339991 | Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa |
| Q36209700 | IELs: enforcing law and order in the court of the intestinal epithelium |
| Q34146449 | IFNαR signaling in effector but not regulatory T cells is required for immune dysregulation during type I IFN-dependent inflammatory disease. |
| Q33920273 | IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes |
| Q35156282 | IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function |
| Q34432872 | IL-35-mediated induction of a potent regulatory T cell population. |
| Q57471546 | IL-6 Promotes T Cell Proliferation and Expansion under Inflammatory Conditions in Association with Low-Level RORγt Expression |
| Q39498874 | IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression |
| Q58271921 | IL2 is required for functional maturation of regulatory T cells |
| Q90699199 | Immune predictors of oral poliovirus vaccine immunogenicity among infants in South India |
| Q36024794 | Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses |
| Q52588288 | Immunization of proteins from Toxascaris leonina adult worm inhibits allergic specific Th2 response. |
| Q42182305 | Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs |
| Q35685195 | Immunological mechanisms in specific immunotherapy. |
| Q35222593 | Immunology of inflammatory bowel disease and molecular targets for biologics |
| Q92326866 | Immunomodulation of Murine Chronic DSS-Induced Colitis by Tuftsin-Phosphorylcholine |
| Q35857951 | Immunopathogenesis of IBD: current state of the art. |
| Q36626285 | Immunopathogenesis of IBD: insufficient suppressor function in the gut? |
| Q36823884 | Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34. |
| Q80643410 | In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells |
| Q34629722 | In vivo Treg suppression assays |
| Q56898935 | Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients |
| Q57253491 | Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation |
| Q91247417 | Increased frequency of regulatory T cells in pediatric inflammatory bowel disease at diagnosis: a compensative role? |
| Q46383587 | Inducible nitric oxide synthase-dependent DNA damage in mouse model of inflammatory bowel disease |
| Q39761506 | Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection |
| Q33752706 | Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor |
| Q79899596 | Induction of organ-selective CD4+ regulatory T cell homing |
| Q36228356 | Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens |
| Q37945495 | Inflammatory bowel disease: is it a primary immunodeficiency? |
| Q37755254 | Influence of FOXP3 on CD4+CD25+ regulatory T cells |
| Q36014379 | Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. |
| Q42561612 | Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function. |
| Q35558867 | Injury, sepsis, and the regulation of Toll-like receptor responses |
| Q37953824 | Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger |
| Q36024783 | Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation |
| Q33966409 | Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis |
| Q36835789 | Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy |
| Q37055805 | Interleukin-2 and regulatory T cells in graft-versus-host disease |
| Q37073886 | Interleukin-35: odd one out or part of the family? |
| Q34222959 | Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease |
| Q37642857 | Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity |
| Q48875369 | Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis |
| Q33999367 | Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot |
| Q38125275 | Keeping the bowel regular: the emerging role of Treg as a therapeutic target in inflammatory bowel disease. |
| Q90607909 | Kynurenine plays an immunosuppressive role in 2,4,6-trinitrobenzene sulfate-induced colitis in mice |
| Q30441305 | Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice |
| Q36366156 | Layers of mutualism with commensal bacteria protect us from intestinal inflammation |
| Q51990332 | Lentivirally Transduced Recipient-derived Dendritic Cells Serve to Ex Vivo Expand Functional FcRγ-sufficient Double-negative Regulatory T Cells. |
| Q37185263 | Leptin antagonist ameliorates chronic colitis in IL-10⁻/⁻ mice |
| Q38263650 | Lessons from rodent models in celiac disease |
| Q36592984 | Leukocyte Trafficking to the Small Intestine and Colon |
| Q89495140 | Lineage Tracking the Generation of T Regulatory Cells From Microbial Activated T Effector Cells in Naïve Mice |
| Q34661115 | Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells. |
| Q37655753 | Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo |
| Q39414393 | Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity |
| Q51770870 | Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. |
| Q40349858 | Lymph node trafficking of regulatory T cells is prerequisite for immune suppression |
| Q24805793 | Lymphopenia and autoimmune diseases |
| Q48163963 | MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells. |
| Q48020859 | MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis |
| Q64110701 | Maf deficiency in T cells dysregulates T - T17 balance leading to spontaneous colitis |
| Q28083298 | Manipulating regulatory T cells: a promising strategy to treat autoimmunity |
| Q36884751 | Mapping the New World of Necrotizing Enterocolitis (NEC): Review and Opinion |
| Q22251072 | Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis |
| Q34615216 | Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases |
| Q36078047 | Mechanisms of suppression by suppressor T cells |
| Q37125569 | Mesenchymal Cells of the Intestinal Lamina Propria |
| Q33836834 | Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets |
| Q38997053 | Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation |
| Q42149272 | MicroRNA 26a prolongs skin allograft survival and promotes regulatory T cell expansion in mice |
| Q85648663 | MicroRNA-26a Promotes Regulatory T cells and Suppresses Autoimmune Diabetes in Mice |
| Q38130307 | Microbial activation of gut dendritic cells and the control of mucosal immunity |
| Q33902387 | Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis |
| Q42210265 | Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo |
| Q44632333 | Modulation of tryptophan catabolism by regulatory T cells. |
| Q50671091 | Molecular Mechanisms of Regulatory T Cell Development and Suppressive Function |
| Q34291997 | Mucosal T cells in gut homeostasis and inflammation |
| Q36148741 | Mucosal T lymphocytes--peacekeepers and warriors |
| Q45053078 | Mucosal dendritic cells in immunity and inflammation |
| Q39001317 | Multifunctional activity of a small tellurium redox immunomodulator compound, AS101, on dextran sodium sulfate-induced murine colitis |
| Q34496728 | Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivo |
| Q41825885 | Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cells. |
| Q50972710 | Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice |
| Q34076106 | Natural Foxp3(+) regulatory T cells inhibit Th2 polarization but are biased toward suppression of Th17-driven lung inflammation |
| Q82872924 | Natural IgE production in the absence of MHC Class II cognate help |
| Q36563554 | Natural regulatory T cells and parasites: a common quest for host homeostasis |
| Q36078038 | Natural regulatory T cells and self-tolerance |
| Q36078051 | Natural regulatory T cells in infectious disease |
| Q33818748 | Natural regulatory T cells in malaria: host or parasite allies? |
| Q51986019 | Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells. |
| Q37251333 | Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen |
| Q36711904 | Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. |
| Q36278029 | Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo |
| Q37361936 | New insights into the roles of dendritic cells in intestinal immunity and tolerance |
| Q42933111 | Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice |
| Q36938431 | Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis |
| Q33750800 | Ontogeny of FOXP3(+) regulatory T cells in the postnatal human small intestinal and large intestinal lamina propria |
| Q36755475 | Oral Delivery of Particulate Transforming Growth Factor Beta 1 and All-Trans Retinoic Acid Reduces Gut Inflammation in Murine Models of Inflammatory Bowel Disease |
| Q38553186 | Oxygen sensing in intestinal mucosal inflammation |
| Q34997285 | PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs |
| Q35644875 | Parasites and the hygiene hypothesis: regulating the immune system? |
| Q35535481 | Parasitic helminth cystatin inhibits DSS-induced intestinal inflammation via IL-10(+)F4/80(+) macrophage recruitment |
| Q50130381 | Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25high FOXP3+ Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy. |
| Q37076945 | Peripherally induced tregs - role in immune homeostasis and autoimmunity |
| Q35923305 | Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury |
| Q85185759 | Polyclonal Expansion of Human CD4+CD25+ Regulatory T Cells |
| Q38235166 | Potential and limitations of regulatory T-cell therapy in solid organ transplantation. |
| Q38774063 | Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy |
| Q35871046 | Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China. |
| Q36615982 | Probiotics increase T regulatory cells and reduce severity of experimental colitis in mice |
| Q35892424 | Program death-1 regulates peripheral T cell tolerance via an anergy-independent mechanism |
| Q41075955 | Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability |
| Q54095003 | Protective function of Bu Shen Huo Xue formula on the immunity of B6AF1 mice with experimental autoimmune premature ovarian failure. |
| Q33712391 | Protein phosphatase 4 is an essential positive regulator for Treg development, function, and protective gut immunity |
| Q35053414 | Radiation Enhances Regulatory T Cell Representation |
| Q42392644 | Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development |
| Q37349757 | Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages |
| Q24796969 | Regulating the immune system: the induction of regulatory T cells in the periphery |
| Q43003993 | Regulatory CD4+CD25+ cells reverse imbalances in the T cell pool of bone marrow transplanted TGepsilon26 mice leading to the prevention of colitis. |
| Q38927531 | Regulatory T Cells: Central Concepts from Ontogeny to Therapy |
| Q37981391 | Regulatory T cell migration during an immune response |
| Q37599669 | Regulatory T cells and immune tolerance to tumors |
| Q36975739 | Regulatory T cells and infection: a dangerous necessity |
| Q36079900 | Regulatory T cells and intestinal homeostasis |
| Q37349778 | Regulatory T cells and the induction of IL-17. |
| Q37607071 | Regulatory T cells as therapeutic targets in rheumatoid arthritis |
| Q54332931 | Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model. |
| Q37624578 | Regulatory T cells for the prevention of graft-versus-host disease: professionals defeat amateurs. |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q36455974 | Regulatory T cells in human disease and their potential for therapeutic manipulation |
| Q36549731 | Regulatory T cells in microbial infection |
| Q37220846 | Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis |
| Q24816793 | Regulatory T cells in rheumatoid arthritis |
| Q37691776 | Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role? |
| Q37374092 | Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia |
| Q82291935 | Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitis |
| Q34966662 | Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. |
| Q36563545 | Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation |
| Q36911411 | Regulatory T cells--the renaissance of the suppressor T cells. |
| Q36117973 | Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis |
| Q36421407 | Regulatory T-cell compartmentalization and trafficking |
| Q36891917 | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. |
| Q34075568 | Regulatory T-cell stability and plasticity in mucosal and systemic immune systems |
| Q37986197 | Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers |
| Q36999506 | Reishi Protein LZ-8 Induces FOXP3(+) Treg Expansion via a CD45-Dependent Signaling Pathway and Alleviates Acute Intestinal Inflammation in Mice |
| Q46718334 | Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis |
| Q90268996 | Resolution of Crohn's disease |
| Q33555986 | Restoring the balance: immunotherapeutic combinations for autoimmune disease |
| Q42944527 | Retinoic acid‐induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation |
| Q56975194 | Role of IFNγ in Allograft Tolerance Mediated by CD4+CD25+Regulatory T Cells by Induction of IDO in Endothelial Cells |
| Q24816917 | Role of regulatory T cells in experimental arthritis and implications for clinical use. |
| Q37090518 | Role of regulatory T cells in gastrointestinal inflammatory disease |
| Q54746044 | Roles of T cell-associated L-selectin and β7 integrins during induction and regulation of chronic colitis. |
| Q36395001 | STAT3 in immune responses and inflammatory bowel diseases |
| Q85244059 | Salmon cartilage proteoglycan suppresses mouse experimental colitis through induction of Foxp3+ regulatory T cells |
| Q28512213 | Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells |
| Q33617796 | Selective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation |
| Q37701348 | Self-tolerance and autoimmunity in a regulatory T cell model |
| Q34422330 | Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy. |
| Q28474036 | Specific immunosuppression with inducible Foxp3-transduced polyclonal T cells |
| Q33473900 | Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells |
| Q42971257 | Suppressor T cells in human diseases |
| Q33772861 | Synergy of Transforming Growth Factor Beta 1 and All Trans Retinoic Acid in the Treatment of Inflammatory Bowel Disease: Role of Regulatory T cells |
| Q37100252 | T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade |
| Q35836118 | T cells in the control of organ-specific autoimmunity |
| Q42253706 | T regulatory cell suppression of colitis: the role of TGF-beta |
| Q49332393 | TGF-β-Induced CD8+CD103+ Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells |
| Q51143427 | TNFΔARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery |
| Q39471157 | Tailoring gut immune responses with lipoteichoic acid-deficient Lactobacillus acidophilus |
| Q37266104 | Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. |
| Q43280097 | Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis |
| Q40425093 | Targeting Antigens to Dec-205 on Dendritic Cells Induces Immune Protection in Experimental Colitis in Mice |
| Q46209104 | Technical Advance: a new cell preparation strategy that greatly improves the yield of vital and functional Tregs and NKT cells |
| Q35611022 | Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. |
| Q49832796 | The Alternative NF-κB Pathway in Regulatory T Cell Homeostasis and Suppressive Function. |
| Q64923754 | The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. |
| Q40113685 | The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function |
| Q92911291 | The Ussing chamber system for measuring intestinal permeability in health and disease |
| Q89422869 | The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy |
| Q37274250 | The development and function of regulatory T cells |
| Q34157927 | The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease |
| Q33838591 | The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function |
| Q34216426 | The immunological and genetic basis of inflammatory bowel disease |
| Q28258462 | The inhibitory cytokine IL-35 contributes to regulatory T-cell function |
| Q42112037 | The kinetics of CD4+Foxp3+ T cell accumulation during a human cutaneous antigen-specific memory response in vivo |
| Q28510411 | The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells |
| Q35523783 | The plasticity of regulatory T cell function |
| Q30439653 | The primary defect in experimental ileitis originates from a nonhematopoietic source |
| Q34651531 | The role of CD4 T cells in the pathogenesis of murine AIDS. |
| Q36118690 | The role of gut-associated lymphoid tissues and mucosal defence |
| Q36164906 | The role of mucosal T lymphocytes in regulating intestinal inflammation |
| Q24803832 | The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells |
| Q36026027 | The role of regulatory T lymphocytes in asthma pathogenesis |
| Q37311051 | The role of stem cell transplantation in inflammatory bowel disease |
| Q33709343 | The role of the T cell in autoimmune inflammation |
| Q38336873 | The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells |
| Q52674851 | Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside. |
| Q80165547 | Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis |
| Q37265675 | Therapeutic evaluation of ex vivo-generated versus natural regulatory T-cells in a mouse model of chronic gut inflammation. |
| Q33684806 | Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. |
| Q36211855 | Therapeutic targeting of alpha 4-integrins in chronic inflammatory diseases: tipping the scales of risk towards benefit? |
| Q42116282 | Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice |
| Q36719265 | Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN. |
| Q91045855 | Thymic regulatory T cells arise via two distinct developmental programs |
| Q93377252 | Tipping the balance: inhibitory checkpoints in intestinal homeostasis |
| Q47304352 | Tissue-specific emergence of regulatory and intraepithelial T cells from a clonal T cell precursor. |
| Q89957112 | Toll-Interacting Protein Regulates Immune Cell Infiltration and Promotes Colitis-Associated Cancer |
| Q34557118 | Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells |
| Q94599497 | Toll-like receptor signaling in thymic epithelium controls monocyte-derived dendritic cell recruitment and Treg generation |
| Q37186819 | Toll-like receptor signalling on Tregs: to suppress or not to suppress? |
| Q43676127 | Tonsillar CD4+CD25+ regulatory T cells from IgA nephropathy patients have decreased immunosuppressive activity in experimental IgA nephropathy rats |
| Q90321771 | Total CD3 T Cells Are Necessary and Sufficient to Induce Colitis in Immunodeficient Mice With Dendritic Cell-Specific Deletion of TGFbR2: A Novel IBD Model to Study CD4 and CD8 T-Cell Interaction |
| Q38085432 | Toward quantifying the thymic dysfunctional state in mouse models of inflammatory bowel disease. |
| Q61783468 | Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance |
| Q37632472 | Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation |
| Q43203199 | Treatment of Crohn's disease with colony-stimulating factors: An overview |
| Q54534513 | Treatment of autoimmune ovarian disease by co-administration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells. |
| Q36497238 | Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. |
| Q36711547 | Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease |
| Q34128432 | Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function |
| Q39205799 | Type I and III Interferon in the Gut: Tight Balance between Host Protection and Immunopathology. |
| Q37863515 | Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations |
| Q47121682 | Update on Dendritic Cell-Induced Immunological and Clinical Tolerance. |
| Q47986758 | Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down? |
| Q41958444 | Vitamin A Impairs the Reprogramming of Tregs into IL-17-Producing Cells during Intestinal Inflammation |
| Q81261692 | [T-lymphocytes--do they control rheumatic immune responses?] |
| Q55040522 | [The traditional Chinese medicine Lulongzaisheng decoction may affect the expression of Foxp3 by regulation of Akt and Stat3 phosphorylation in CD4+CD25+ regulatory T cells from severe aplastic anemia mouse models]. |
| Q89047059 | mTOR Complex 1 Signaling Regulates the Generation and Function of Central and Effector Foxp3+ Regulatory T Cells |
| Q33609703 | β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells |
Search more.